NK cells in COVID-19-from disease to vaccination.

Hammer, Quirin; Cuapio, Angelica; Bister, Jonna; Björkström, Niklas K; Ljunggren, Hans-Gustaf

Hammer, Quirin; Cuapio, Angelica; Bister, Jonna; Björkström, Niklas K; Ljunggren, Hans-Gustaf.

Afiliação

Hammer Q; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Stockholms län, 141 52 Huddinge, Sweden.
Cuapio A; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Stockholms län, 141 52 Huddinge, Sweden.
Bister J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Stockholms län, 141 52 Huddinge, Sweden.
Björkström NK; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Stockholms län, 141 52 Huddinge, Sweden.
Ljunggren HG; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Alfred Nobels allé 8, Stockholms län, 141 52 Huddinge, Sweden.

J Leukoc Biol ; 114(5): 507-512, 2023 10 26.

Article em En | MEDLINE | ID: mdl-36976012

Assuntos

COVID-19; Humanos; SARS-CoV-2; Células Matadoras Naturais; Citocinas; Vacinação

Palavras-chave

COVID-19; SARS-CoV-2; inflammation; natural killer cells; pathogenesis; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google